David A. Siegel Trans Medics Group, Inc. Transaction History

Two Sigma Advisers, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$53.63 - $82.33 $112,623 - $172,893	2,100 Added 3.73%	58,400 $4.42 Million
Q4 2022 Feb 14, 2023	BUY	$39.08 - $64.29 $1.77 Million - $2.91 Million	45,300 Added 411.82%	56,300 $3.47 Million
Q3 2022 Nov 14, 2022	BUY	$31.56 - $55.75 $347,160 - $613,250	11,000 New	11,000 $459,000

388

31.4M

465K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.31B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.